Scotland’s bioeconomy gets scale-up boost

Reproducible nanopore sequencing to be commercialised from 2026

New way to target mitochondrial diseases

Countdown to SLAS Europe: ThirdLaw Molecular Inc.

BioNTech Secures £129m UK Backing